(Q43724329)

26 November 2017

Growth and immortalization of human myeloma cells in immunodeficient severe combined immunodeficiency mice: a preclinical model (English)

1 reference

severe combined immunodeficiency

26 November 2017

1 reference

Rème T

1

1 reference

26 November 2017

Gueydon E

2

1 reference

26 November 2017

Jacquet C

3

1 reference

26 November 2017

Klein B

4

1 reference

26 November 2017

Brochier J

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

British Journal of Haematology

26 November 2017

1 reference

26 November 2017

114

1 reference

26 November 2017

406-413

1 reference

26 November 2017

2

1 reference

The C.B.17 scid mouse strain as a model for human disseminated leukaemia and myeloma in vivo

26 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

False human hematopoietic cell lines: cross-contaminations and misinterpretations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Introduction of a normal retinoblastoma (Rb) gene into Rb-deficient lymphoblastoid cells delays tumorigenicity in immunodefective mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

The beige mutation in the mouse selectively impairs natural killer cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Mechanisms of bone lesions in multiple myeloma and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02947.X

10.1046/J.1365-2141.2001.02947.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference